Rapid Micro Biosystems annual capital expenditures (capex)
2020
2021
2022
2023
2024
2025
Rapid Micro Biosystems Capital Expenditures (CapEx) Growth & History (RPID)
Rapid Micro Biosystems's capital expenditures (capex) was $850,000 for fiscal 2025.
View full Rapid Micro Biosystems company overviewRapid Micro Biosystems annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $850,000 | −$515,000 | −37.73% |
| 2024 | 2024-12-31 | $1.4M | −$480,000 | −26.02% |
| 2023 | 2023-12-31 | $1.8M | −$4.9M | −72.63% |
| 2022 | 2022-12-31 | $6.7M | $3.5M | +109.51% |
| 2021 | 2021-12-31 | $3.2M | $2.5M | +366.23% |
| 2020 | 2020-12-31 | $690,000 | — | — |
Rapid Micro Biosystems quarterly capital expenditures (capex)
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $223,000 | −$143,000 | −39.07% |
| Q1 2026 | 2026-03-31 | $394,000 | $75,000 | +23.51% |
| Q4 2025 | 2025-12-31 | $92,000 | −$6,000 | −6.12% |
| Q3 2025 | 2025-09-30 | $73,000 | −$150,000 | −67.26% |
| Q2 2025 | 2025-06-30 | $366,000 | −$93,000 | −20.26% |
| Q1 2025 | 2025-03-31 | $319,000 | −$266,000 | −45.47% |
| Q4 2024 | 2024-12-31 | $98,000 | −$320,000 | −76.56% |
| Q3 2024 | 2024-09-30 | $223,000 | −$230,000 | −50.77% |
| Q2 2024 | 2024-06-30 | $459,000 | $244,000 | +113.49% |
| Q1 2024 | 2024-03-31 | $585,000 | −$174,000 | −22.92% |
| Q4 2023 | 2023-12-31 | $418,000 | −$393,000 | −48.46% |
| Q3 2023 | 2023-09-30 | $453,000 | −$1.1M | −71.46% |
| Q2 2023 | 2023-06-30 | $215,000 | −$1.8M | −89.19% |
| Q1 2023 | 2023-03-31 | $759,000 | −$1.6M | −67.74% |
| Q4 2022 | 2022-12-31 | $811,000 | −$1.2M | −58.75% |
| Q3 2022 | 2022-09-30 | $1.6M | $1.1M | +245.75% |
| Q2 2022 | 2022-06-30 | $2.0M | $1.4M | +267.65% |
| Q1 2022 | 2022-03-31 | $2.4M | $2.1M | +837.45% |
| Q4 2021 | 2021-12-31 | $2.0M | — | — |
| Q3 2021 | 2021-09-30 | $459,000 | $285,000 | +163.79% |
| Q2 2021 | 2021-06-30 | $541,000 | — | — |
| Q1 2021 | 2021-03-31 | $251,000 | — | — |
| Q3 2020 | 2020-09-30 | $174,000 | — | — |
Rapid Micro Biosystems capital expenditures (capex) trends
Over the last five fiscal years, Rapid Micro Biosystems's capital expenditures (capex) increased from $690,000 to $850,000, a change of $160,000. The latest reported quarter, Q2 2026, shows $223,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rapid Micro Biosystems source filings ↗